CTRI/2021/09/036701
Completed
未知
Immediate procedural safety and long-term efficacy of Ultra-long 48 mm Xience-Xpedition stents: A real world experience from India
Department of Cardiology0 sites92 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: Z988- Other specified postprocedural states
- Sponsor
- Department of Cardiology
- Enrollment
- 92
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All patients who underwent percutaneous coronary intervention using
- •Xience Xpedition 48 mm long stent (Abbott vascular Santa Clara, CA ) who
- •will be willing to give informed consent
Exclusion Criteria
- •Patients who will not give consent
- •Patients who could not be contacted
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Procedural Safety and Long term Clinical Outcomes in Patients with coronary artery diseaseCTRI/2024/02/062793Sri Ramachandra Institute of Higher Education and Research
Recruiting
Phase 1
Short-term and long-term efficacy and safety evaluation of acupoint catgut embedding in the simple obesity: a randomized controlled double-blind trialITMCTR2200005494The Fifth Affiliated Hospital of Southern Medical University
Completed
Not Applicable
Efficacy trial and long-term safety confirmation test- Efficacy and long-term safety of the test food TK61406 ingested as a single dose, in a double-blind, parallel-group comparison to placebo.A range of individuals from healthy to borderline conditions- Persons with tendency for constipation or diarrhea- Persons classified as normal to 1 degree of obesity- Persons classified with normal to 1 degree of average blood pressureJPRN-jRCT1091220210Tokai Pickling Co.,Ltd. Yasufumi Ohba, Masataka Fujita, Mitsuru Satsukawa, Tetsuhiro Kawamoto, Mika Komura, Shoko Nishio, Tetsuya Iyoda,Hiroshi Ono30
Completed
Phase 4
Evaluation of Long-term efficacy, safety and predictors of Adalimumab in Crohn's disease: Japanese multicenter cohort study (ADJUST study)JPRN-UMIN000014708IBD Center, Sapporo Kosei General Hospital500
Active, not recruiting
Phase 1
Follow-Up clinical trial in patients who have previously received test product RG-101 for assessment of long term safety and efficacyHepatitis C PatientsMedDRA version: 19.0Level: PTClassification code 10019744Term: Hepatitis CSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 19.0Level: PTClassification code 10008912Term: Chronic hepatitis CSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 19.0Level: LLTClassification code 10019761Term: Hepatitis cytomegalovirusSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 19.0Level: LLTClassification code 10057394Term: Hepatitis C positiveSystem Organ Class: 100000004848MedDRA version: 19.0Level: LLTClassification code 10019760Term: Hepatitis CMVSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 19.0Level: LLTClassification code 10047457Term: Viral hepatitis CSystem Organ Class: 10021881 - Infections and infestationsTherapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2016-002069-77-HURegulus Therapeutics Inc.200